Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3064% below fair value
$12.97+0.11 (+0.86%)
Close on Nov 13, 2026Market cap $145.04MP/E –Yield 0.00%
Medifast profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Medifast's profit margin for the twelve months ending Sep 30, 2026 was -13.6%. For fiscal 2025 it was -4.8%, against 0.3% the year before. The highest annual figure on record is 11.1% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.8% | −5.2 |
| FY2024 | Dec 31, 2024 | 0.3% | −8.9 |
| FY2023 | Dec 31, 2023 | 9.3% | +0.3 |
| FY2022 | Dec 31, 2022 | 9.0% | −1.8 |
| FY2021 | Dec 31, 2021 | 10.7% | −0.3 |
| FY2020 | Dec 31, 2020 | 11.0% | +0.1 |
| FY2019 | Dec 31, 2019 | 10.9% | −0.2 |
| FY2018 | Dec 31, 2018 | 11.1% | +1.9 |
| FY2017 | Dec 31, 2017 | 9.2% | +2.7 |
| FY2016 | Dec 31, 2016 | 6.5% | −0.9 |
| FY2015 | Dec 31, 2015 | 7.4% | +2.7 |
| FY2014 | Dec 31, 2014 | 4.6% | −2.8 |
| FY2013 | Dec 31, 2013 | 7.4% | +2.4 |
| FY2012 | Dec 31, 2012 | 5.0% | −1.2 |
| FY2011 | Dec 31, 2011 | 6.2% | −1.4 |
| FY2010 | Dec 31, 2010 | 7.6% | +0.9 |
| FY2009 | Dec 31, 2009 | 6.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -24.3% | −21.8 |
| Q2 FY2026 | Jun 30, 2026 | -4.1% | −6.4 |
| Q1 FY2026 | Mar 31, 2026 | -2.8% | −2.1 |
| Q4 FY2025 | Dec 31, 2025 | -24.1% | −24.8 |
| Q3 FY2025 | Sep 30, 2025 | -2.5% | −3.3 |
| Q2 FY2025 | Jun 30, 2025 | 2.3% | +7.2 |
| Q1 FY2025 | Mar 31, 2025 | -0.7% | −5.4 |
| Q4 FY2024 | Dec 31, 2024 | 0.7% | −2.5 |
| Q3 FY2024 | Sep 30, 2024 | 0.8% | −9.0 |
| Q2 FY2024 | Jun 30, 2024 | -4.8% | −15.1 |
| Q1 FY2024 | Mar 31, 2024 | 4.8% | −6.7 |
| Q4 FY2023 | Dec 31, 2023 | 3.2% | −4.7 |
| Q3 FY2023 | Sep 30, 2023 | 9.8% | +0.5 |
| Q2 FY2023 | Jun 30, 2023 | 10.2% | +1.6 |
| Q1 FY2023 | Mar 31, 2023 | 11.5% | +1.4 |
| Q4 FY2022 | Dec 31, 2022 | 7.9% | −1.1 |
| Q3 FY2022 | Sep 30, 2022 | 9.3% | −0.9 |
| Q2 FY2022 | Jun 30, 2022 | 8.6% | −3.3 |
| Q1 FY2022 | Mar 31, 2022 | 10.0% | −2.0 |
| Q4 FY2021 | Dec 31, 2021 | 9.0% | −1.6 |
| Q3 FY2021 | Sep 30, 2021 | 10.2% | −2.5 |
| Q2 FY2021 | Jun 30, 2021 | 11.9% | +1.9 |
| Q1 FY2021 | Mar 31, 2021 | 12.1% | +1.7 |
| Q4 FY2020 | Dec 31, 2020 | 10.6% | −1.1 |
| Q3 FY2020 | Sep 30, 2020 | 12.7% | +4.3 |
| Q2 FY2020 | Jun 30, 2020 | 10.0% | −1.5 |
| Q1 FY2020 | Mar 31, 2020 | 10.4% | −2.2 |
| Q4 FY2019 | Dec 31, 2019 | 11.7% | +0.9 |
| Q3 FY2019 | Sep 30, 2019 | 8.4% | −1.5 |
| Q2 FY2019 | Jun 30, 2019 | 11.4% | −0.6 |
| Q1 FY2019 | Mar 31, 2019 | 12.5% | +0.1 |
| Q4 FY2018 | Dec 31, 2018 | 10.7% | +1.4 |
| Q3 FY2018 | Sep 30, 2018 | 9.9% | +1.2 |
| Q2 FY2018 | Jun 30, 2018 | 12.0% | +2.0 |
| Q1 FY2018 | Mar 31, 2018 | 12.4% | +3.7 |
| Q4 FY2017 | Dec 31, 2017 | 9.4% | +2.8 |
| Q3 FY2017 | Sep 30, 2017 | 8.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 10.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 8.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 6.6% | – |
See a number that looks wrong?